MORGAN STANLEY PLC/CALL/MEDTRONIC/140/0.1/20.12.24 Share Price

Warrant

DE000MB8SLG1

Market Closed - Börse Stuttgart 09:37:06 28/06/2024 pm IST
0.04 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/MEDTRONIC/140/0.1/20.12.24
Current month+81.82%
1 month+90.48%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 0.04 0.00%
27/24/27 0.04 0.00%
26/24/26 0.04 -2.44%
25/24/25 0.041 0.00%
24/24/24 0.041 -4.65%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 09:37 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN MB8SLG
ISINDE000MB8SLG1
Date issued 14/07/2023
Strike 140 $
Maturity 20/12/2024 (174 Days)
Parity 10 : 1
Emission price 0.09
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.132
Lowest since issue 0.011
Delta0.05x
Omega 8.575
Premium78.07x
Gearing177.37x
Moneyness 0.5634
Difference Strike 61.29 $
Difference Strike %+43.78%
Spread 0.003
Spread %6.98%
Theoretical value 0.0415
Implied Volatility 45.12 %
Total Loss Probability 97.54 %
Intrinsic value 0.000000
Present value 0.0415
Break even 140.44 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus